Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy
Immune checkpoint blockade (ICB) therapy targeting PD-L1 via monoclonal antibody (mAb) has shown extensive clinical benefits in the diverse types of advanced malignancies. However, most patients are completely refractory to ICB therapy owing to the PD-L1 recycling mechanism. Herein, we propose photo...
Príomhchruthaitheoirí: | , , , , , , , , , |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Elsevier
2024-03-01
|
Sraith: | Acta Pharmaceutica Sinica B |
Ábhair: | |
Rochtain ar líne: | http://www.sciencedirect.com/science/article/pii/S221138352300360X |